New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - lamivudine 5 mg/ml;   - oral solution - 5 mg/ml - active: lamivudine 5 mg/ml   excipient: banana flavour 59.256 ap0551 citric acid hydrochloric acid methyl hydroxybenzoate propyl hydroxybenzoate propylene glycol purified water sodium citrate dihydrate sodium hydroxide strawberry flavour 057883 ap0551 sucrose - zeffix is indicated for the treatment of adults and children aged 2 years and older with chronic hepatitis b and evidence of hepatitis b virus (hbv) replication.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - aciclovir 200mg; aciclovir 200mg - dispersible tablet - 200 mg - active: aciclovir 200mg excipient: aluminium magnesium silicate hypromellose indigo carmine macrogol 400 macrogol 8000 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate active: aciclovir 200mg excipient: aluminium magnesium silicate hypromellose macrogol 400 macrogol 8000 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate titanium dioxide - zovirax dispersible tablets are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. zovirax dispersible tablets are indicated for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. zovirax dispersible tablets are indicated for the prophylaxis of herpes simplex infections in immune-compromised patients.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - aciclovir 400mg; aciclovir 400mg - dispersible tablet - 400 mg - active: aciclovir 400mg excipient: aluminium magnesium silicate hypromellose iron oxide red macrogol 400 macrogol 8000 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate active: aciclovir 400mg excipient: aluminium magnesium silicate hypromellose macrogol 400 macrogol 8000 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate titanium dioxide - zovirax dispersible tablets are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. zovirax dispersible tablets are indicated for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. zovirax dispersible tablets are indicated for the prophylaxis of herpes simplex infections in immune-compromised patients.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - aciclovir 800mg - dispersible tablet - 800 mg - active: aciclovir 800mg excipient: aluminium magnesium silicate hypromellose macrogol 400 macrogol 8000 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate titanium dioxide - zovirax dispersible tablets are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. zovirax dispersible tablets are indicated for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. zovirax dispersible tablets are indicated for the prophylaxis of herpes simplex infections in immune-compromised patients.

European Union - English - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human; immunization; disease outbreaks - vaccines - active immunisation against h5n1 subtype of influenza a virus.this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of vaccine prepared from a/vietnam/1194/2004 nibrg-14 (h5n1) (see section 5.1).prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals 3.75 µg should be used in accordance with official guidance.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - lamivudine 150mg;   - film coated tablet - 150 mg - active: lamivudine 150mg   excipient: magnesium stearate microcrystalline cellulose opadry white ys-1-7706-g sodium starch glycolate - 3tc in combination with other anti-retroviral agents is indicated for the treatment of hiv infected adults and children.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - lamivudine 300mg;   - film coated tablet - 300 mg - active: lamivudine 300mg   excipient: magnesium stearate microcrystalline cellulose opadry grey ys-1-17506a sodium starch glycolate

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - lamivudine 10 mg/ml;   - oral solution - 10 mg/ml - active: lamivudine 10 mg/ml   excipient: banana flavour 59.256 ap0551 citric acid methyl hydroxybenzoate propyl hydroxybenzoate propylene glycol purified water sodium citrate dihydrate strawberry flavour 057883 ap0551 sucrose - 3tc in combination with other anti-retroviral agents is indicated for the treatment of hiv infected adults and children.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - benzoyl peroxide 66.7 mg/g; clindamycin phosphate 12.8 mg/g;   - topical gel - 1%w/w, 5%w/w - active: benzoyl peroxide 66.7 mg/g clindamycin phosphate 12.8 mg/g   excipient: carbomer 940 colloidal silicon dioxide dimeticone disodium edetate dihydrate disodium lauryl sulfosuccinate glycerol poloxamer purified water sodium hydroxide - for the topical treatment of comedo, papular and pustular acne vulgaris.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - isotretinoin 0.05%{relative} (2% overage added);   - topical gel - 0.05% w/w - active: isotretinoin 0.05%{relative} (2% overage added)   excipient: butylated hydroxytoluene ethanol hyprolose - isotrex gel is indicated for the topical treatment of mild to moderate acne vulgaris, characterised by papules and pustules.